Ask an Expert
Orally disintegrating tablets
Q: How can we include orally disintegrating tablets in our portfolio cost-effectively and also be FDA compliant?
Whether you're taking advantage of the ANDA regulatory pathway to adapt a conventional tablet or you're developing a new product, you'll face unique challenges in developing a commercially approved, orally disintegrating tablet (ODT).
More Questions and Answers
Dwell time during tablet compression
Q: How do turret velocity and the design of punch head flats affect dwell time during tablet compression with a rotary tablet press?
Dwell time, expressed in milliseconds, is the amount of time required for tablet punches to achieve maximum penetration into the die bore under the main compression rollers and to no longer be moving vertically. In other words, dwell time occurs when the compression rollers are in contact with the punch head flat.
In Tablets & Capsules magazine
Benefits of capsules over tablets for optimizing product performance and improving patient compliance
While tablets and capsules are both safe and viable dosage forms, capsules compare favorably to tablets in a number of ways, including: cost savings and ease of manufacturing, control of highly potent APIs, ease of swallowing, attractiveness, and ease of use in combination products.
To find more information about suppliers at the Tablets & Capsules
website, click here.
Events and continuing education
June 28, 2021
T&C Solid Dosage Sourcebook